APRAMEYA ENGINEERING LTD Stock Price Today (NSE: APRAMEYA)
Fundamental Score
APRAMEYA ENGINEERING LTD Share Price — Live NSE/BSE Price, Fundamentals & Analysis
APRAMEYA ENGINEERING LTD share price today is ₹146.00, up +0.00% on NSE/BSE as of 3 August 2026. APRAMEYA ENGINEERING LTD (APRAMEYA) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹285.51 (Cr). The 52-week high for APRAMEYA share price is ₹360.00 and the 52-week low is ₹145.00. At a P/E ratio of 56.65x, APRAMEYA is currently trading above its industry average P/E of 36.70x. The company has a Return on Equity (ROE) of 7.54% and a debt-to-equity ratio of 0.10.
APRAMEYA ENGINEERING LTD Share Price Chart — NSE/BSE Historical Performance
APRAMEYA ENGINEERING LTD share price chart: -3.70% return over the past month. 52-week high ₹360.00, 52-week low ₹145.00.
APRAMEYA ENGINEERING LTD — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹148.40 | ₹150.00 | ₹145.00 | ₹147.10 | 24.00K (Cr) | |
| ₹147.00 | ₹149.00 | ₹147.00 | ₹148.50 | 2.50K (Cr) | |
| ₹150.00 | ₹152.50 | ₹146.25 | ₹147.15 | 4.00K (Cr) | |
| ₹146.05 | ₹153.00 | ₹146.05 | ₹149.20 | 6.50K (Cr) | |
| ₹147.05 | ₹153.00 | ₹147.05 | ₹149.00 | 3.00K (Cr) | |
| ₹150.00 | ₹153.00 | ₹150.00 | ₹153.00 | 2.00K (Cr) | |
| ₹152.00 | ₹152.00 | ₹148.15 | ₹148.15 | 1.00K (Cr) | |
| ₹150.00 | ₹153.80 | ₹150.00 | ₹153.80 | 1.00K (Cr) | |
| ₹151.05 | ₹154.55 | ₹149.95 | ₹149.95 | 2.50K (Cr) | |
| ₹152.75 | ₹153.75 | ₹152.75 | ₹153.40 | 4.00K (Cr) |
APRAMEYA ENGINEERING LTD — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹152.10 | ₹154.55 | ₹145.00 | ₹147.10 | -3.29% | |
| ₹158.85 | ₹162.50 | ₹156.00 | ₹158.20 | -0.41% | |
| ₹228.00 | ₹237.95 | ₹169.15 | ₹173.00 | -24.12% | |
| ₹209.00 | ₹242.00 | ₹209.00 | ₹221.30 | +5.89% | |
| ₹206.55 | ₹227.00 | ₹206.55 | ₹216.35 | +4.74% | |
| ₹280.00 | ₹280.00 | ₹237.00 | ₹250.00 | -10.71% | |
| ₹296.25 | ₹297.00 | ₹234.05 | ₹267.00 | -9.87% | |
| ₹337.85 | ₹338.00 | ₹299.10 | ₹315.00 | -6.76% | |
| ₹281.20 | ₹360.00 | ₹270.05 | ₹345.05 | +22.71% | |
| ₹285.30 | ₹299.00 | ₹250.00 | ₹274.00 | -3.96% | |
| ₹283.00 | ₹285.00 | ₹262.05 | ₹275.00 | -2.83% |
AI Research Briefing
Powered by Gemini · 2026-04-17
Micro-cap play on Indian medical infrastructure build-out, but liquidity risk looms large.
WHAT'S HAPPENING NOW
No major catalysts found after live search. Aprameya Engineering's share price 28% increase from its previous closing. The stock is trading 40.96% below its 52-week high of
CORE STORY
- Industry growth projections are strong
- Government support via PLI scheme
- High ROE of 35%
- Significant new order wins
- Faster execution of existing orders
- Increased FII/DII interest
- Micro-cap liquidity risk
- High PEG ratio indicates overvaluation
- Reliance on EPC companies for revenue
FII holdings decreased by 0.41%
Expanding healthcare infrastructure and government support provide a tailwind
No - Negative free cash flow of ₹-21.06 Cr over 5 years
Aprameya needs to demonstrate consistent order execution and maintain margins to justify its valuation. Monitor working capital closely.
Primary Thesis Risk
Inability to scale operations and manage working capital could derail growth.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
APRAMEYA ENGINEERING LTD Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
APRAMEYA ENGINEERING LTD Fundamental Analysis & Valuation Benchmarking
Educational evaluation of APRAMEYA across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Strong Operating Margins (16.45%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Consistent Growth Track Record (16.12% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (42.43% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.10)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (74.05%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Below-Average Return on Equity (7.54%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Premium Valuation Risk (P/E: 56.65x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-109.64%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-90.03%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Institutional Interest (FII+DII: 0.70%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
APRAMEYA ENGINEERING LTD vs Medical Equipment & Supplies Peers
Peer Comparison - Medical Equipment & Supplies
Compare APRAMEYA ENGINEERING LTD with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
38.2/100 | ₹146.00₹146 | ₹285.51₹285.51 | 56.65Average 56.6 Average | 7.54%Poor 7.54% Poor | 12.64%Average 12.64% Average | 0.10Excellent 0.1 Excellent | 42.43%Excellent 42.43% Excellent | 16.12%Excellent 16.12% Excellent | 0.00% | |
Poly Medicure LtdPoly Medicure L... POLYMED • 531768 | 55.6/100 | ₹1702.00₹1702 | ₹17395.50₹17395.50 | 53.16Average 53.2 Average | 11.15%Average 11.15% Average | 14.04%Average 14.04% Average | 0.11Excellent 0.1 Excellent | 19.35%Excellent 19.35% Excellent | 19.02%Excellent 19.02% Excellent | 0.20% |
Fischer Medical Ventures LtdFischer Medical... FISCHER • 524743 | 21.9/100 | ₹39.13₹39 | ₹2522.43₹2522.43 | 81.32Average 81.3 Average | 8.59%Poor 8.59% Poor | 11.43%Average 11.43% Average | 0.28Excellent 0.3 Excellent | — — | — — | 0.01% |
Tarsons Products LtdTarsons Product... TARSONS • 543399 | 17.1/100 | ₹314.60₹315 | ₹1588.16₹1588.16 | 105.46Average 105.5 Average | 2.38%Poor 2.38% Poor | 4.56%Poor 4.56% Poor | 0.62Good 0.6 Good | -26.20%Poor -26.20% Poor | 13.04%Good 13.04% Good | 0.00% |
Laxmi Dental LtdLaxmi Dental Lt... LAXMIDENTL • 544339 | 69.6/100 | ₹212.69₹213 | ₹1227.22₹1227.22 | 36.70Average 36.7 Average | 14.80%Average 14.80% Average | 14.86%Average 14.86% Average | 0.05Excellent 0.1 Excellent | 103.10%Excellent 103.10% Excellent | 24.69%Excellent 24.69% Excellent | 0.00% |
OSEL DEVICES LIMITEDOSEL DEVICES LI... OSELDEVICE • | 67.9/100 | ₹413.05₹413 | ₹782.87₹782.87 | 26.76Average 26.8 Average | 19.56%Good 19.56% Good | 24.40%Excellent 24.40% Excellent | 0.49Excellent 0.5 Excellent | 84.72%Excellent 84.72% Excellent | 38.54%Excellent 38.54% Excellent | 0.00% |
HSIL LimitedHSIL Limited... HSIL • 543916 | 64.4/100 | ₹376.20₹376 | ₹547.99₹547.99 | 30.06Average 30.1 Average | 18.19%Good 18.19% Good | 19.64%Good 19.64% Good | 0.36Excellent 0.4 Excellent | 68.05%Excellent 68.05% Excellent | 31.02%Excellent 31.02% Excellent | 0.00% |
Prevest Denpro LtdPrevest Denpro ... PREVEST • 543363 | 61.5/100 | ₹401.65₹402 | ₹465.72₹465.72 | 21.74Average 21.7 Average | 18.51%Good 18.51% Good | 24.67%Excellent 24.67% Excellent | 0.00Excellent 0.0 Excellent | 24.33%Excellent 24.33% Excellent | 20.33%Excellent 20.33% Excellent | 0.26% |
Nureca LtdNureca Ltd... NURECA • 543264 | 16.5/100 | ₹343.60₹344 | ₹260.07₹260.07 | 123.84Average 123.8 Average | 1.12%Poor 1.12% Poor | 3.30%Poor 3.30% Poor | 0.01Excellent 0.0 Excellent | -46.15%Poor -46.15% Poor | -7.19%Poor -7.19% Poor | 0.00% |
20.7/100 | ₹110.60₹111 | ₹216.85₹216.85 | 21.41Average 21.4 Average | 10.45%Average 10.45% Average | 13.18%Average 13.18% Average | 0.65Good 0.7 Good | — — | — — | 0.45% | |
32.1/100 | ₹193.50₹194 | ₹215.42₹215.42 | 23.96Average 24.0 Average | 11.99%Average 11.99% Average | 15.14%Good 15.14% Good | 0.03Excellent 0.0 Excellent | — — | — — | 0.00% | |
Top Medical Equipment & Supplies Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Poly Medicure Ltd share price17395.50 Cr
- Fischer Medical Ventures Ltd share price2522.43 Cr
- Tarsons Products Ltd share price1588.16 Cr
- Laxmi Dental Ltd share price1227.22 Cr
- OSEL DEVICES LIMITED share price782.87 Cr
APRAMEYA ENGINEERING LTD Quarterly Performance
Latest quarterly metrics for APRAMEYA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-90.03%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-109.64%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
16.12%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
42.43%
Compounded annual net profit growth over 5 years
APRAMEYA ENGINEERING LTD Technical Indicators
SMA 50, SMA 200, RSI and volume signals for APRAMEYA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
APRAMEYA ENGINEERING LTD Financial Statements
Annual income statement, balance sheet and cash flow for APRAMEYA ENGINEERING LTD (APRAMEYA) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for APRAMEYA ENGINEERING LTD
About APRAMEYA (APRAMEYA ENGINEERING LTD)
APRAMEYA ENGINEERING LTD (APRAMEYA) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Medical Equipment & Supplie...s sector with a current market capitalisation of ₹285.51 (Cr). APRAMEYA ENGINEERING LTD has delivered a Return on Equity (ROE) of 7.54% and a ROCE of 12.64%. The debt-to-equity ratio stands at 0.10, reflecting the company's capital structure. Investors tracking APRAMEYA share price can monitor key metrics including P/E ratio, promoter holding of 74.05%, and quarterly earnings growth.
Company Details
APRAMEYA Share Price: Frequently Asked Questions
What is the current share price of APRAMEYA ENGINEERING LTD?
APRAMEYA ENGINEERING LTD (APRAMEYA) trades at ₹146.00 on NSE. Market cap ₹285.51 (Cr). Educational data only.
What is the P/E ratio of APRAMEYA ENGINEERING LTD?
APRAMEYA ENGINEERING LTD has a P/E of 56.65x vs industry average 36.70x.
What is the Bull Run score for APRAMEYA ENGINEERING LTD?
APRAMEYA ENGINEERING LTD has a Bull Run score of 38.2/100 based on 25+ financial parameters.
Does APRAMEYA ENGINEERING LTD pay dividends?
APRAMEYA ENGINEERING LTD has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of APRAMEYA ENGINEERING LTD?
APRAMEYA ENGINEERING LTD has ROE of 7.54%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of APRAMEYA ENGINEERING LTD?
APRAMEYA ENGINEERING LTD has debt-to-equity of 0.10.
Is APRAMEYA ENGINEERING LTD a good investment?
Bull Run gives APRAMEYA ENGINEERING LTD a score of 38.2/100. This is not investment advice — consult a SEBI-registered advisor.